Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection

Clinical Infectious Diseases

Volumn 34, Issue 7, 2002, Pages 944-948

  Wald, Anna ^a,b   Carrell, David ^a   Remington, Michael ^a   Kexel, Elizabeth ^a   Zeh, Judy ^a,c   Corey, Lawrence ^a,d  

^a Departments of Laboratory Medicine   (United States)

^b Health Services and Epidemiology   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; SEX DIFFERENCE; TREATMENT OUTCOME; VIRUS SHEDDING;

ACYCLOVIR; ADULT; AGED; ANTIVIRAL AGENTS; DOUBLE-BLIND METHOD; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; MALE; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME;

EID: 0036532218     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/339325     Document Type: Article

References (14)

1. 1998 Guidelines for treatment of sexually transmitted diseases
2. Comparison of Western blot (Immunoblot) and G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera
3. Diagnosis of herpes simplex virus by direct immunofluorescence and viral isolation from samples of external genital lesions in a high prevalence population
4. Valaciclovir versus acyclovir in patient-initiated treatment of recurrent genital herpes: A randomized, double-blind clinical trial
5. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections
6. Patient-initiated, twice-daily oral famcidovir for early recurrent genital herpes: A randomized, double-blind multicenter trial
7. Virologic characteristics of subclinical and symptomatic genital herpes infections
8. Treatment of recurrent genital herpes simplex infections with oral acyclovir: A controlled trial
9. Risk of recurrence after treatment of first episode genital herpes with intravenous acyclovir
10. Recurrence rates in genital herpes after symptomatic first-episode infection
11. A large-scale, placebo-controlled, dose-ranging trial of peroral valacyclovir for episodic treatment of recurrent herpes genitalis
12. A comparison of oral valaciclovir 500 mg twice daily for three or five days in the treatment of recurrent genital herpes
13. A randomized, double-blind, comparative trial comparing high and standard dose oral acyclovir for first-episode genital herpes infections
14. Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: A large-scale dose range-finding study